Phase 1 Immunotherapy Trial With Two Chimeric HER-2 B-Cell Peptide Vaccines Emulsified in Montanide ISA 720VG and Nor-MDP Adjuvant in Advanced Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3997
Full Text
Open PDFAbstract
Available in full text
Date
February 25, 2019
Authors
Publisher
American Association for Cancer Research (AACR)